🚀 VC round data is live in beta, check it out!
Sedana Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sedana Medical and similar public comparables like Rapid Micro Biosystems, Zomedica, Susmed, Neuronetics and more.
Sedana Medical Overview
About Sedana Medical
Sedana Medical AB is a Sweden-based medical technology company. It is a pioneer MedTech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. The group's product range is Sedaconda ACD, Sedaconda, AnaConDa, FlurAbsorb, Gas Monitor, Adapters, and Accessories. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.
Founded
2005
HQ
Employees
109
Website
Financials (LTM)
EV
$96M
Sedana Medical Financials
Sedana Medical reported last 12-month revenue of $23M and negative EBITDA of ($1M).
In the same LTM period, Sedana Medical generated ($1M) in EBITDA losses and had net loss of ($6M).
Revenue (LTM)
Sedana Medical P&L
In the most recent fiscal year, Sedana Medical reported revenue of $23M and EBITDA of ($1M).
Sedana Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $23M | XXX | $23M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $16M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 69% | XXX | XXX | XXX |
| EBITDA | ($1M) | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | (4%) | XXX | (5%) | XXX | XXX | XXX |
| EBIT Margin | (15%) | XXX | (16%) | XXX | XXX | XXX |
| Net Profit | ($6M) | XXX | ($6M) | XXX | XXX | XXX |
| Net Margin | (24%) | XXX | (29%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sedana Medical Stock Performance
Sedana Medical has current market cap of $105M, and enterprise value of $96M.
Market Cap Evolution
Sedana Medical's stock price is $1.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $96M | $105M | 0.4% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSedana Medical Valuation Multiples
Sedana Medical trades at 4.2x EV/Revenue multiple, and (94.1x) EV/EBITDA.
EV / Revenue (LTM)
Sedana Medical Financial Valuation Multiples
As of April 18, 2026, Sedana Medical has market cap of $105M and EV of $96M.
Equity research analysts estimate Sedana Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sedana Medical has a P/E ratio of (19.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $105M | XXX | $105M | XXX | XXX | XXX |
| EV (current) | $96M | XXX | $96M | XXX | XXX | XXX |
| EV/Revenue | 4.2x | XXX | 4.3x | XXX | XXX | XXX |
| EV/EBITDA | (94.1x) | XXX | (84.7x) | XXX | XXX | XXX |
| EV/EBIT | (27.2x) | XXX | (27.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.2x | XXX | XXX | XXX |
| P/E | (19.0x) | XXX | (16.3x) | XXX | XXX | XXX |
| EV/FCF | (12.1x) | XXX | (11.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sedana Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sedana Medical Margins & Growth Rates
Sedana Medical's revenue in the last 12 month grew by 11%.
Sedana Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Sedana Medical's rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sedana Medical's rule of X is 15% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sedana Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | (4%) | XXX | (5%) | XXX | XXX | XXX |
| EBITDA Growth | (86%) | XXX | (34%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 4% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 15% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 49% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 26% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 85% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sedana Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sedana Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Rapid Micro Biosystems | XXX | XXX | XXX | XXX | XXX | XXX |
| Zomedica | XXX | XXX | XXX | XXX | XXX | XXX |
| Susmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Neuronetics | XXX | XXX | XXX | XXX | XXX | XXX |
| C-Rad | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sedana Medical M&A Activity
Sedana Medical acquired XXX companies to date.
Last acquisition by Sedana Medical was on XXXXXXXX, XXXXX. Sedana Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sedana Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSedana Medical Investment Activity
Sedana Medical invested in XXX companies to date.
Sedana Medical made its latest investment on XXXXXXXX, XXXXX. Sedana Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sedana Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sedana Medical
| When was Sedana Medical founded? | Sedana Medical was founded in 2005. |
| Where is Sedana Medical headquartered? | Sedana Medical is headquartered in Sweden. |
| How many employees does Sedana Medical have? | As of today, Sedana Medical has over 109 employees. |
| Who is the CEO of Sedana Medical? | Sedana Medical's CEO is Johannes Doll. |
| Is Sedana Medical publicly listed? | Yes, Sedana Medical is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Sedana Medical? | Sedana Medical trades under SEDANA ticker. |
| When did Sedana Medical go public? | Sedana Medical went public in 2017. |
| Who are competitors of Sedana Medical? | Sedana Medical main competitors are Rapid Micro Biosystems, Zomedica, Susmed, Neuronetics. |
| What is the current market cap of Sedana Medical? | Sedana Medical's current market cap is $105M. |
| What is the current revenue of Sedana Medical? | Sedana Medical's last 12 months revenue is $23M. |
| What is the current revenue growth of Sedana Medical? | Sedana Medical revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Sedana Medical? | Current revenue multiple of Sedana Medical is 4.2x. |
| Is Sedana Medical profitable? | No, Sedana Medical is not profitable. |
| What is the current EBITDA of Sedana Medical? | Sedana Medical has negative EBITDA and is not profitable. |
| What is Sedana Medical's EBITDA margin? | Sedana Medical's last 12 months EBITDA margin is (4%). |
| What is the current EV/EBITDA multiple of Sedana Medical? | Current EBITDA multiple of Sedana Medical is (94.1x). |
| What is the current FCF of Sedana Medical? | Sedana Medical's last 12 months FCF is ($8M). |
| What is Sedana Medical's FCF margin? | Sedana Medical's last 12 months FCF margin is (35%). |
| What is the current EV/FCF multiple of Sedana Medical? | Current FCF multiple of Sedana Medical is (12.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.